Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a combination dietary supplement containing three antioxidant nutrients—lutein, beta-carotene, and vitamin E. Lutein is a carotenoid that accumulates in the retina and macula of the eye, where it acts as a light filter and protects ocular tissues from oxidative damage. Beta-carotene is another carotenoid with provitamin A activity; it can be converted by the body into vitamin A as needed. Vitamin E (primarily in the form of alpha-tocopherol) is a fat-soluble antioxidant that helps protect cell membranes from oxidative stress. This combination has been studied for its potential to support eye health, particularly in reducing progression of age-related macular degeneration (AMD). Clinical trials such as AREDS have shown benefits for similar combinations; however, later studies suggest that lutein may be preferable to beta-carotene due to safety concerns with high-dose beta-carotene in smokers[1][4][5]. The mechanism of action involves antioxidation and protection against free radical-induced cellular damage.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on lutein + beta carotene + vitamin e.